Results 11 to 20 of about 19,470 (278)
Dermoscopy of disorders of hypopigmentation
Pigment International, 2022 Dermoscopy has traditionally been used to diagnose neoplasms and, more recently, to evaluate inflammatory conditions. Recent observational studies have suggested a role for dermoscopy in identifying and differentiating various hypopigmentary disorders ...
Yasmeen Jabeen Bhat +2 more
doaj +2 more sources
Adipose-Derived Mesenchymal Stem Cell Secretome for Post-Steroid Hypopigmentation and Skin Atrophy: A Case Report. [PDF]
Case Rep Dermatol MedYusharyahya SN +2 more
europepmc +3 more sources
Molecules, 2023 We investigated the effects of four coumarin derivatives, namely, 6-methylcoumarin, 7-methylcoumarin, 4-hydroxy-6-methylcoumarin, and 4-hydroxy-7-methylcoumarin, which have similar structures on melanogenesis in a murine melanoma cell line from a C57BL ...
Taejin Kim, Jin-Kyu Kang, Chang-Gu Hyun
doaj +1 more source
A differential genome-wide transcriptome analysis : impact of cellular copper on complex biological processes like aging and development [PDF]
, 2012 The regulation of cellular copper homeostasis is crucial in biology. Impairments lead to severe dysfunctions and are known to affect aging and development.
Grimm, Carolin +3 more
core +8 more sources
Total Hemi-overgrowth in Pigmentary Mosaicism of the (Hypomelanosis of) Ito Type: Eight Case Reports. [PDF]
, 2016 Pigmentary mosaicism of the (hypomelanosis of) Ito type is an umbrella term, which includes phenotypes characterized by mosaic hypopigmentation in the form of streaks, whorls, patchy, or more bizarre skin configurations (running along the lines of ...
Corsello G +8 more
core +1 more source
Ayurvedic management of Shvitra (~vitiligo): A case report
Journal of Ayurveda Case Reports, 2023 Vitiligo, a depigmenting disorder affecting 1%–2% of the world’s population, is a chronic skin disease, characterized by the appearance of white depigmented macules and patches due to loss of melanocytes.
Pratik Sharma +2 more
doaj +1 more source
Further Analyses of the Safety of Verubecestat in the Phase 3 EPOCH Trial of Mild-To-Moderate Alzheimer’s Disease [PDF]
, 2019 Background: Verubecestat, a BACE1 inhibitor that reduces Aβ levels in the cerebrospinal fluid of humans, was not effective in a phase 3 trial (EPOCH) of mild-to-moderate AD and was associated with adverse events.
Aisen, Paul S. +12 more
core +3 more sources
Extragenital Blaschkoid lichen sclerosus et atrophicus in a child [PDF]
, 2018 Lichen sclerosus et atrophicus is a chronic inflammatory skin disease that typically affects prepubertal girls and peri- or post-menopausal women in genital and perineal areas. In some cases, it can also manifest as extragenital lesions.
Albornoz, Christian A +2 more
core +2 more sources